Trial intelligence / Profile preview

Dexamethasone for post-dural puncture headache after orthopedic surgery

IRCT20200412047041N1Phase 3Completed

Sponsor
Jiroft University of Medical Sciences
Start
Jan 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of dexamethasone in post-dural puncture headache (PDPH), sponsored by Jiroft University of Medical Sciences. Primary endpoint: Headache after spinal anesthesia in orthopedic patients. Started Jan 2015; status: completed.

02

Drugs

dexamethasone
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT20200412047041N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200412047041N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call